View in EDS HTML Full Text PDF Full Text

Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer.

Saved in:

Bibliographic Details
Title:	Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer.
Authors:	Vida, Riccardo^1,2 (AUTHOR), Bartoletti, Michele² (AUTHOR) michele.bartoletti@cro.it, Lerda, Lucia³ (AUTHOR), Corsetti, Serena^2,4 (AUTHOR), Scalone, Simona^2,5 (AUTHOR), Calabrò, Anna^4,6 (AUTHOR), Caroli, Angela^5,7 (AUTHOR), Rizzetto, Monica^1,2,8 (AUTHOR), Zapelloni, Giulia^1,2,9 (AUTHOR), Caccin, Elisabetta^6,10 (AUTHOR), Fucina, Stefano^7,11 (AUTHOR), Bortolin, Giorgia⁸ (AUTHOR), Cecco, Sara⁸ (AUTHOR), Baldo, Paolo⁸ (AUTHOR), Pignata, Sandro⁹ (AUTHOR), Califano, Daniela¹⁰ (AUTHOR), Canzonieri, Vincenzo^3,11 (AUTHOR), Ditto, Antonino⁷ (AUTHOR), Puglisi, Fabio^1,2 (AUTHOR)
Source:	Current Oncology. Nov2025, Vol. 32 Issue 11, p596. 8p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	11980052
DOI:	10.3390/curroncol32110596